MedTrace Logo

Satisfaction & Spectacle Independence With ReSTOR 2.5 & ReSTOR 3.0 IOLs

NCT03073681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-06-05

No results posted yet for this study

Summary

Patients implanted with the ReSTOR 2.5 multifocal IOL in the dominant eye and the ReSTOR 3.0 in the non-dominant eye have overall satisfaction and spectacle independence at least comparable to that with bilateral implantation of the 3.0 add lens. Glare and haloes and other unwanted visual side effects with this mixed combination of lenses is better than with bilateral 3.0 lenses.

Conditions

  • Cataract

Interventions

DEVICE

Survey

Patients will complete a survey describing their satisfaction with vision after cataract surgery that was performed at least 2 months prior to study enrollment.

Sponsors & Collaborators

  • MDbackline, LLC

    lead OTHER

Principal Investigators

  • John Hovanesian, MD · MDbackline, LLC

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-03
Primary Completion
2019-05-22
Completion
2019-05-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073681 on ClinicalTrials.gov